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Abstract  
Introduction: Perceived control is an important concept in understanding adjustment to chronic 
conditions such as Parkinson’s. While generic measures have been used to measure the construct 
in Parkinson’s, no Parkinson’s-specific scale currently exists. This study outlines the initial 
development and further validation of a free-to-use scale, the Parkinson’s UK Scale of Perceived 
Control (PUKSoPC). 
Method: Focus groups were used to create items for the new scale. Potential items were then 
subject to screening for readability and coherence by people affected by the condition. This left 
49 items that were then completed, along with other measures, by 231 people with Parkinson’s. 
Exploratory factor analysis then created a 15-item scale with five distinct subscales. This initial 
structure was then further tested using confirmatory factor analysis with 2032 people with 
Parkinson’s. Structural equation modelling confirmed the acceptability of the total scale and 
subscale structures. 
Results: The final scale is concluded to be a psychometrically robust measure of perceived 
control. It has good face validity, evidence of convergent and criterion (concurrent and 
divergent) validity, good test-retest reliability and is internally coherent, with a demonstrably 
solid factor structure. While further testing would be useful to assess the scale’s predictive 
ability, it is currently considered robust enough for more widespread use.  
Conclusion: The PUKSoPC is an appropriate scale to provide a more comprehensive measure of 
perceived control. It is preferable to single item, non-validated measures and can provide 
evidence of perceptions of control across a number of domains important in the measurement of 
the construct.  
 
 
 
 
Highlights: 
 Perceptions of control are important in determining psychological wellbeing  
 No current scale exists to measure adaptive control in people with Parkinson’s 
 A new psychometrically valid scale is presented 
 This scale has excellent psychometric properties and is free to use 
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1. Introduction 
Perceived control is an important concept in influencing how people adapt to life with a 
chronic condition such as Parkinson’s [1]. For example, higher levels of perceived 
control correlate with a range of more positive outcomes, such as better mood [2], and 
higher quality of life generally [3]. Control has been measured as a trait-like variable and 
this is what is most usually measured in more generic measures of perceived control [4]. 
However, perceived control can also be experienced over a number of illness-specific 
domains – e.g., belief in an individual’s ability to control the progress of the condition 
generally and symptoms more specifically [5]. It is also a factor influencing how a 
condition affects lives outside the more narrow parameters of illness-defined 
symptomatic experience – e.g., how much control is experienced over access to health 
services in relation to a condition.  In addition, when controlling the condition or 
symptoms is not possible, the control of emotional reactions and the ability to adapt to 
a new situation becomes important [6] as well as perceived control over other life 
domains and living well despite the condition [3]. Evidence also suggests that control 
can be manipulated therapeutically, with concomitant effects on psychological well-
being [7].  
However, despite its importance as a theoretical construct [1], no measure of control 
specifically created for people with Parkinson’s currently exists. Previous research 
employing the theoretical concept has largely used general measures of control over 
illness [3]. Although these can be useful for making comparisons across patient groups, 
they are not as sensitive to the specific issues faced by people with such a diverse and 
unpredictable condition; in this sense they lack ‘face validity’ as they cannot include 
items which might not be relevant to a much wider population [8]. Moreover, scales need 
to be constructed so higher scores are indicative of adaptive levels of perceived control 
and this is not possible with single item measures such as ‘how much control do you feel 
you have over your condition’. For example, a  scale where stronger agreement on an 
item indicative of unrealistic aspirations of control (e.g. I have full control over the 
progress of my condition’) would result in a higher ‘perceived control’ score. However, 
this is unlikely to reflect a realistic (or adaptive) sense of control given the limitations 
faced by individuals with an unpredictable chronic condition [9]. Furthermore, such a 
scale would not correlate in meaningful ways with other scales where there should be 
some degree of concurrent validity, such as scales of well-being. Consequently, 
perceptions of adaptive levels of control are best measured using a range of outcomes 
considered important for demonstrating perceived control. However, this necessitates 
detailed preparatory work on a condition-specific basis to identify specific outcomes 
indicative of effective control across domains considered most important for those with 
the condition. The measurement of control from an individual perspective is also 
consistent with the move to incorporate patient reported outcomes (PROMs) in both 
assessment and outcome studies [10]. These measures privilege the view of the 
participant and in relation to measures that are concerned with views or perceptions of 
the self, they are seen as offering an important additional perspective to measures rated 
by others (e.g. family, other professionals) in PD research [11]. Moreover, condition 
specific PROMs have been increasingly developed for use with people with Parkinson’s 
[e.g. 12].  
Consequently, this study reports the development of a psychometrically valid scale to 
measure individuals with Parkinson’s levels of their perception of the effectiveness of 
their control strategies with respect to their condition. It reports initial validation, with the 
creation of a provisional factor structure and further validation with a much larger 
sample. 
2. Methods 
2.1 Participants  
For the scale creation, 49 potential scale items were sent by Parkinson’s UK, a UK 
national charity for people with Parkinson’s, to a group of around 1700 people affected 
by Parkinson’s; 236 responses were received, with 231 retained for analysis (see 
demographic in Table 1). Smaller samples can also be acceptable when communalities 
are high and factors are strongly determined [13] and using MacCallum et al.’s [13] 
guidelines a sample of 200 was thought likely to be sufficient. 
A second set of data for further validation was collected from 2032 members of 
Parkinson’s UK (see Table 1). The age of participants was again wide-ranging, with 846 
(42%) female. This participant number is appropriate given that the purpose of the 
second sample was to confirm the initial factor solution and is sufficient for 
asymptotically distribution-free (ADF) estimation. 
[Insert Table 1 here] 
2.2 Procedure  
2.2.1 Initial item generation  
The scale was created using best practice guidance for scale creation [14]. Focus groups 
of people with Parkinson’s, recruited from Parkinson’s UK, generated ideas to form the 
basis of the scale’s items. Specifically, individuals were asked to consider how they 
would consider whether they had achieved appropriate and reasonable levels of control 
of their condition given that they had a chronic condition affecting multiple domains. A 
range of areas were cited as being potentially affected by perceptions of control – for 
example, the effects of control on their general well-being – i.e. their stress levels – and 
their level of external engagement. As already indicated, this much wider sampling of 
areas related to control is more sensitive than research which has simply asked single 
item questions [e.g. 5].  
This process led to the generation of an initial pool of 84 items with both positively and 
negatively worded questions (i.e. reverse scored items). People affected by Parkinson’s 
reviewed these 84 items for face validity, and to ensure readability and acceptability. 
This resulted in changes to phrasing of some items. In addition, the negatively worded 
questions were removed as they were thought to be potentially problematic for those 
individuals who were experiencing difficulties in cognitive flexibility and perseveration. 
Reverse scored items can also cause contamination of data if respondents are inattentive 
or become confused. Items were also critically reviewed for length and possible overlap. 
These assessments led to a final pool of 49 items.  
2.2.2 Scale creation  
The 49 items, with other demographic and questionnaire items, were sent to potential 
participants. As part of this initial validation, other data also collected included: standard 
demographic details (gender, age, age at symptom onset, age at diagnosis, ethnicity, and 
living arrangements) and two previously validated measures of control to provide data on 
the new scale’s concurrent validity. The two measures were: 
General self-efficacy scale (GSE) [15].  
This scale assesses individuals’ sense of agency, i.e. how much they feel able to 
overcome difficulties and solve problems in life. It is a well-known scale of general (i.e. 
non health specific) control with good psychometric properties which has been validated 
internationally [16] with Cronbach alpha ranging from .75 to .91 [16]. In the current 
sample α=.94. 
Self-efficacy for managing chronic disease-6 item scale [7,17].  
This scale also assesses personal agency but in relation to managing a chronic health 
condition and continuing with everyday activities despite the condition. It is a short form 
of the original 32 item scale and has a high internal consistency (α=.91) [17]. In the 
current sample α=.93. 
In order to assess concurrent and divergent validity, we assessed the scale against the 
emotional well-being and stigma subscales of the Parkinson’s Disease Quality of Life 
Scale (PDQ-39) [18]. This 39-item questionnaire assesses patient-reported quality of life 
across eight subscales. It is a widely used measure of the construct and has high internal 
consistency in both its total and subscale structures [19] and in this study, for the stigma 
subscale, α=.82 and for emotional well-being, α=.91. 
Administration and completion of the scale (median completion=24mins) was conducted 
electronically aided by Smart Survey (https://www.smartsurvey.co.uk/). The work 
described has been conducted in line with The Code of Ethics of the World Medical 
Association (Declaration of Helsinki) for studies involving humans. The analysis was 
reviewed and approved by the Faculty of Health and Medicine Research Ethics 
Committee, Lancaster University (REF:S2014-72). 
For the second stage of the validation, the same data collection and consent procedures 
were applied. This time, however, only the PUKSoPC was sent to participants.  
2.3 Statistical analysis  
Most statistical analyses were conducted using the Statistical Package for Social Sciences 
(SPSS) (version 22.0). Confirmatory factor analysis was conducted using AMOS 
(version 22.0; IBM Corp.) to fit the Structural Equation Model (SEM). Descriptive 
statistics (mean, standard deviation [SD]) were assessed. For all analyses, a two tailed p 
value of ≤.05 was used to denote statistical significance. 
In order to develop the psychometric properties of the scale for the creation of the initial 
solution, intra-item correlations between the 49 potential items of the new scale were 
examined. Items with mainly low correlations (<.30) with other items were removed as 
not representing the same underlying construct[20]. 
A principal axis exploratory factor analysis was then conducted on the remaining items 
with oblique rotation (direct oblimin, delta = 0). Exploratory factor analysis was chosen 
as this is suitable for identifying latent constructs [13,21,22] and the principal axis 
method was utilized as this does not have distributional assumptions [21] and certain 
items were negatively skewed. Oblique rotation was selected as the factors were expected 
to correlate and this approach permits examination of how the factors are related [21]. 
The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy tests whether the 
patterns of correlations are likely to be appropriate for factor analysis. A score of >.8 is 
considered excellent [23]. 
Convergent, concurrent and divergent validity was measured using Pearson’s r, with 
scores of ≥0.5 considered acceptable [24]. 
The confirmatory factor model was tested on the five factor solution previously 
identified, with a total score also viable and based on the total of the five individual 
subscales. Parameters were estimated with ADF estimates to yield optimal parameter 
estimates, due to non-normal distributions [25]. A chi-squared test was used to assess the 
fitness of the data to the hypothesized model, although it was noted that the chi-square 
test may report significant difference re model fit with sample sizes N>400 [26]. 
Model fit indices, such as the comparative fit index (CFI), the root mean square error of 
approximation (RMSEA), and the chi-squared statistic divided by the degrees of freedom 
(CMIN/df) were considered. An acceptable model is indicated by a CFI of ≥0.95, an 
RMSEA of ≤0.06 [27] and a CMIN/df  of <3.0 [28]. 
Modification indices that made a significant contribution to the model (i.e. a modification 
index value of >10) were adjusted as appropriate; positively correlated error terms were 
the only modifications applied to the model. 
Cronbach’s alpha was used for testing the degree of the inter-relatedness among the items 
in the final solutions. A value above 0.7 is considered acceptable [22]. The presence of 
floor or ceiling effects were considered if 15% of respondents scored, respectively, the 
lowest or highest scores on the scale [29].  
3. Results  
For the initial validation, of the 236 responses received, 231 complete data sets were 
included.  
3.1 Exploratory factor analysis  
Eleven items with low correlations with other items were removed [23], reducing the 
total to 38. After this exclusion, for the data as a whole KMO=.94, with individual items 
also all above .8. 
The remaining items were subject to an exploratory factor analysis. An initial analysis 
was conducted to obtain eigenvalues for each factor. Using Kaiser's criterion (retaining 
factors with eigenvalues greater than one), this generated a six factor solution which 
explained 61.6% of the variance (see Table 2). However, when deciding how many 
factors to extract, a number of considerations should be taken into account including the 
need to balance “parsimony” with “plausibility” [21]. 
[Insert Table 2 here] 
Consequently, the number of factors was critically assessed and one of the factors 
(factor 5) was not felt to be robust enough to stand-alone. A five-factor model was felt to 
offer a more plausible model with factors that were separate enough to be meaningful.  
Considering these various recommendations, the data indicate five clearly interpretable 
factors: 1) “do things”; 2) “get informed”; 3) “make plans”; 4) “think positive”; and 5) 
“be involved”. 
3.2 Scale construction  
When choosing items for the final scale from the structure reported above, items were 
chosen which had high factor loadings on the intended factor and which appeared to 
represent the breadth of each construct. To ensure a balanced final scale, three items were 
chosen from each of the five interpretable factors. As the final factor “get involved” only 
had two items with significant loadings, a third item was included from the original pool 
of items, which just missed being included in the initial analyses (see Appendix 1). 
A principal axis exploratory factor analysis with direct oblimin rotation, forcing a five-
factor solution generated the pattern matrix (see Table 3); the five factors explained 
64.8% of the variance (a highly acceptable level of variance). As can be seen all items 
load ‘cleanly’ onto the expected factor, with no items cross loading. 
[Insert Table 3 here] 
Correlations were conducted between the final version of the scale with the two other 
measures of control. As expected, the total score of the new scale correlated highly with 
the general self-efficacy scale (r=.548; p<.01) and the condition specific measure 
(r=608; p<.01); this pattern was also replicated for the control scale subscales (all 
r>.269; all p<.01), indicating good concurrent validity. The correlation between the new 
control scale and the PDQ-39 subscale of emotional well-being was in the predicted 
direction (more control, less problems with emotional well-being) and significant (r=-
.467; p<.01), indicating convergent validity. Control and stigma, as measured by the 
PDQ-39, also negatively correlated (r=-.351; p<.01) in the predicted direction (less 
control, more problems with stigma), indicating divergent validity.  
3.3 Confirmatory factor analysis  
As the scale was created on a relatively small sample (N=231), it was important to test 
the model on a larger sample to assess the robustness of the initial factor solution.  
Using confirmatory factor analysis, minimization was successful and the data were 
considered an acceptable fit to the model ([N=2031] χ2=195.42 p<0.001; CMIN/df=2.96, 
RMSEA=0.03 [90% CI 0.03–0.04], CFI=0.96). Figure 1 (see supplementary material) 
displays the final model, including correlations, explained variance, and standardized path 
coefficients for each path. This confirms that the initial factor solution was valid.  
No floor or ceiling effects were found for the PUKSoPC total score (percentages of 
patients achieving low scores, 1.5% and high scores, respectively, 9.9) and the subscales 
Think Positive (1.5/9.9), Get Informed (1.5/6.2), Make Plans (3.7/6.3) and Be Involved 
(9.6/5.8). Only the subscale Do Things showed some evidence of a ceiling effect (17.1).  
The tests of internal reliability of the subscales (Cronbach alpha; Table 4) and total score 
were excellent (all α>.75). Test-reliability was also good (r=.80, N=84). 
[Insert Table 4 here] 
4. Discussion 
The results of the scale construction reflect a robust approach to the development of the 
scale items in terms of an effective measurement of a complex construct and 
comprehensive testing of the initial solution through exploratory and confirmatory factor 
analysis. In relation to the different types of validity necessary to demonstrate a 
psychometrically robust scale, we would argue that because of the active input of people 
with Parkinson’s, the scale has good face validity. It is also clear that from a 
psychometric perspective the initial factor solution held up well to further testing from 
the confirmatory factor analysis stage indicating high construct validity. Furthermore, 
the scale has good concurrent, convergent and divergent validity – as indicated by its 
significant correlations with other measures of perceived control and other constructs 
with which it should positively and negatively co-vary – and strong test re-test 
reliability. Internal consistency on a total scale and subscale basis was excellent.  
In terms of further work, clearly the scale would benefit from further validation; in 
particular its predictive validity – i.e. its ability to predict either psychological indices at 
a future time or other behavioral measures, such as increased use of health services, that 
would be expected to be predicted by higher baseline levels of perceived control. 
Although developed on a UK sample, the questionnaire can be used across population 
groups; the only possible modification would be to item 15, with the suggested addition 
of a more local patient support organization. While there is no reason to suggest that the 
scale would not be suitable for populations outside the UK, data from an international 
perspective would of course be useful. 
Having an effective measure of perceived control means that interventions both on an 
individual and broader level with people with Parkinson’s can now be effectively 
measured. For example, in some psychological interventions, e.g., cognitive behavioral 
therapy, control is specifically targeted given its mediating influence on other quality of 
life domains [30]. On a broader level, in the UK, Parkinson’s UK is using the scale to 
track the change in control on an annual basis from surveys of its members. Finally, the 
scale is free to use and can be administered both online and in a more traditional paper 
format.  
While the scale measures individuals’ perceptions of effective levels of perceived 
control, it should not be assumed that lower scores necessarily reflect individual 
difficulties. While attempts to increase control can be targeted at an individual level, it is 
more likely that systemic factors are equally or even more important [31]. Furthermore, 
while strategies for increasing control can be highlighted for individuals to adopt, 
difficulties reported by people with Parkinson’s often relate to societal attitudes and 
constraints which limit their abilities to exercise control over their life [32]. 
Consequently, lower scores on this scale should be considered in light of individual and 
systemic factors even though the measurement of perceived control is at an individual 
level.  
5. Conclusion 
To conclude, this scale is a valid and reliable PROM that measures the successful 
exercise of control over a number of areas most affected by symptoms and also more 
general domains of control in people with Parkinson’s. It shows high test – retest 
reliability, good convergent, concurrent and divergent validity and excellent construct 
validity. It is hoped that the scale can be used to measure this important construct and 
help provide evidence of interventions that can deliver meaningful change. 
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Tables  
Table 1: Characteristics of samples in first and second validation  
 
 First sample Second sample 
 Value Percentage Value Percentage 
Same size (n) 231  2032  
Mean age in years (SD) 65.9 (9.1)    
Age (n)     
25-34   2 <1 
35-44   20 1 
45-54   149 7 
55-64   317 16 
65-74   771 38 
75 and over   693 34 
Not known   80 4 
Gender (n)   
Female 111 48 846 42 
Male 118 51 1112 55 
Other 0 0 1 <1 
Not known 2 1 73 3 
Ethnic group (n)   
White British 214 93 1895 93 
White Irish 3 1 20 1 
Any other white background 10 4 19 1 
Asian British 1 <1 0 0 
Asian/Asian British - 
Pakistani 0 0 3 < 1 
Asian Chinese 1 <1 1 <1 
Any other Asian background 1 <1 0 0 
Black/Black British - 
Caribbean 0 0 1 <1 
Mixed - White and Black 0 0 1 <1 
Any other Mixed background 0 0 1 <1 
Arab 1 <1 1 <1 
Any other background 0 0 1 <1 
Not known 0 0 89 4 
Living arrangements (n)   
Alone 28 12 316 16 
With others (partners, family 
&friends) 197 85 -    - 
Live with spouse/partner - - 1476 73 
Live with family/friends - - 94 5 
Residential/nursing home 2 1 53 3 
Other - - 21 1 
Not known 4 2 72 4 
Clinical data     
Mean age at symptom onset (SD) 57.9 (9.7) - - - 
Mean age when diagnosed (SD) 59.7 (9.5) - - - 
Time since diagnosis (n)     
Less than 2 years - - 271 13 
2-10 years - - 1197 59 
11-20 years - - 405 20 
21 years and over - - 88 4 
Not known - - 71 4 
The category not known includes both those who left the item blank and those who ticked 
“prefer not to say” when this option was available. 
  
Table 2: Item loadings on the 6 factors 
 Factors 
 1 2 3 4 5 6 
I try to focus on what I can do, 
rather than what I can’t do    -.343   
When things aren’t going well, 
I know how to make myself feel 
better 
  -.519   
I know what to do to stop 
myself worrying    -.829   
I know how to help myself feel 
calm in a stressful situation    -.781   
I try to focus on the positives in 
life    -.640   
I know how to manage my 
stress levels    -.797   
I know how to manage when 
I’m feeling down    -.805   
I feel I have accepted 
Parkinson’s  in my life    -.368   
I know what helps me manage 
my physical symptoms as much 
as possible 
 .613     
I know how Parkinson’s affects 
me 
 .567     
I know where to go to find out 
more information about 
Parkinson’s if I need it 
 .613     
I know about the different 
treatment options for 
Parkinson’s 
 .719     
I know about what forms of 
exercise or other physical 
activities are best for me 
 .461     
I know what are the best foods 
for me to eat  .469     
I have worked out how to make 
my Parkinson’s medication 
work best for me 
 .441     
I try to stay in touch with family 
and/or friends .504      
I know who to go to for support 
when I’m feeling down     .467  
I feel I am a part of a 
community (local or online) .307     .328 
I know who to go to for help 
when I’m worried about 
Parkinson’s  
 .407   .426  
I know I can get support from 
my family or friends when I’m 
struggling with Parkinson’s  
     .315 
I try to pursue hobbies and 
other activities I enjoy when I 
can 
.878      
I try to engage in social 
activities with friends and 
family when I can 
.839      
I try to take part in activities 
that are good for my physical 
health 
.748      
I try to take part in activities 
that are good for my mental 
wellbeing 
.777      
I try to keep my brain active .769      
I try to find ways round 
challenges so that I can 
continue to pursue activities I 
enjoy 
.773      
I try to stay as active as I can .758      
I make time for activities that I 
enjoy .822      
I try to pursue activities that I 
find worthwhile .850      
Note: loadings <0.364 omitted [20] 
  
I try to live life to the full as 
much as I can .743      
I continue to set goals for things 
I would like to achieve .405      
I plan how I will manage if my 
health deteriorates when I am 
out (e.g., I have an off period) 
  .535    
I have ways to help me 
remember to do things   .567    
I organise my diary to ensure 
that I can manage day-to-day 
activities 
  .675    
I ensure my plans are flexible so 
I can adapt them if I need to   .825    
I set myself targets for things I 
would like to do   .503    
I share my expertise in 
Parkinson’s with others 
whenever I can 
     .773 
I help my family and friends to 
learn more about Parkinson’s      .744 
Table 3: Item loadings on the final 5 factor solution with 15 items 
 Final factors 
 1 2 3 4 5 
Think positive      
I try to focus on the positives in 
life .573     
I know how to manage my 
stress levels .866     
I know how to manage when 
I’m feeling down .903     
Get informed      
I know what helps me 
manage my physical 
symptoms as much as 
possible 
   .445  
I know where to go to find 
out more information about 
Parkinson’s if I need it 
   .714  
I know about the different 
treatment options for 
Parkinson’s 
   .653  
Do things      
I try to engage in social 
activities with friends and 
family when I can 
  .755   
I try to take part in activities 
that are good for my physical 
health 
  .849   
I try to take part in activities 
that are good for my mental 
wellbeing 
  .853   
Make plans      
I have ways to help me 
remember to do things 
    .548 
I ensure my plans are 
flexible so I can adapt 
them if I need to 
    .949 
I set myself targets for 
things I would like to do 
    .420 
Be involved      
I share my expertise in 
Parkinson’s with others 
whenever I can 
 .933    
I help my family and 
friends to learn more 
about Parkinson’s 
 .722    
I am involved with a 
national organisation 
(e.g. Parkinson’s UK) 
 .428    
Note: loadings <0.364 omitted [26] 
  
Table 4: Descriptive statistics and internal consistency values for subscales and scale total 
score in the second validation  
 Mean Standard Deviation Cronbach alpha 
Factor 1: Think positive 
Factor 2: Be involved 
Factor 3: Do things 
Factor 4: Get informed 
Factor 5: Make plans 
 
10.74 
8.30 
10.84 
10.23 
9.64 
2.79 
3.49 
3.18 
2.86 
3.01 
.87 
.80 
.86 
.77 
.79 
Total  49.76 12.28  .92 
N = 2032: Note: each subscale total could range from 3 to 15 so the theoretical minimum 
and maximum of the total score are 15 and 75 respectively. 
 
Figure showing final model including correlations, explained variance, and standardized path 
coefficients for each path. 
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Appendix 1: The Parkinson’s UK Scale of Perceived Control (PUKSoPC)  
 
Please think about how much each of the following statements applies to you 
and click the appropriate option. 
 
  Not at 
all 
Only a 
little 
Some 
what 
Quite 
a lot 
Very 
much 
1 I try to focus on the positives in life      
2 I know how to manage my stress levels      
3 I know how to manage when I’m feeling 
down 
     
4 I know what helps me manage my 
physical symptoms as much as possible 
     
5 I know where to go to find out more 
information about Parkinson’s if I need it 
     
6 I know about the different treatment 
options for Parkinson’s 
     
7 I try to engage in social activities with 
friends and family when I can 
     
8 I try to take part in activities that are 
good for my physical health 
     
9 I try to take part in activities that are 
good for my mental wellbeing 
     
10 I have ways to help me remember to do 
things 
     
11 I ensure my plans are flexible so I can 
adapt them if I need to 
     
12 I set myself targets for things I would 
like to do 
     
13 I share my expertise in Parkinson’s with 
others whenever I can 
     
14 I help my family and friends to learn 
more about Parkinson’s 
     
15 I am involved with a national 
organisation (e.g. Parkinson’s UK) 
     
10 
 
Scoring instructions 
Each item is scored as follows  
Not at all 1 
Only a little 2 
Somewhat 3 
Quite a lot 4 
Very much 5 
To calculate the score for each subscale the answers to the following items should be 
summed 
 
Think positive 1 2 3 
Get informed 4 5 6 
Do things 7 8 9 
Make plans 10 11 12 
Be involved 13 14 15 
The total score is the sum of all items (or the sum of the subscales). 
 
 
